Metabolic Dysfunction-Associated Steatotic Liver Disease and Nonalcoholic Fatty Liver Disease Have Similar Clinical Profiles and Mortality

被引：0
|
作者：
Younossi, Zobair
Paik, James M.
Golabi, Pegah
Ong, Janus
Henry, Linda
Alqahtani, Saleh
Nader, Fatema
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-83-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
83-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction- Associated Steatotic Liver Disease: Progress But With Challenges
    Allen, Alina M.
    Pose, Elisa
    Reddy, K. Rajender
    Russo, Mark W.
    Kamath, Patrick S.
    [J]. GASTROENTEROLOGY, 2024, 166 (02) : 229 - 234
  • [32] Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence
    Gao, Jingli
    Li, Yuhao
    Zhang, Yijun
    Zhan, Xin
    Tian, Xue
    Li, Junjuan
    Wang, Ru
    He, Yan
    Wang, Anxin
    Wu, Shouling
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (05):
  • [33] Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease
    Kanwal, Fasiha
    Neuschwander-Tetri, Brent A.
    Loomba, Rohit
    Rinella, Mary E.
    [J]. HEPATOLOGY, 2024, 79 (05) : 1212 - 1219
  • [34] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [35] Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
    Beygi, Mohammad
    Ahi, Salma
    Zolghadri, Samaneh
    Stanek, Agata
    [J]. NUTRIENTS, 2024, 16 (14)
  • [36] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
    Sawada, Keisuke
    Chung, Hak
    Softic, Samir
    Moreno-Fernandez, Maria E.
    Divanovic, Senad
    [J]. CELL METABOLISM, 2023, 35 (11) : 1852 - 1871
  • [37] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [38] Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
    Tanaka, Marenao
    Mori, Kazuma
    Takahashi, Satoko
    Higashiura, Yukimura
    Ohnishi, Hirofumi
    Hanawa, Nagisa
    Furuhashi, Masato
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (03) : 700 - 711
  • [39] Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology
    Portincasa, Piero
    Baffy, Gyorgy
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 35 - 39
  • [40] Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease
    Long, Qichen
    Luo, Fengming
    Li, Binghui
    Li, Ziyang
    Guo, Zhe
    Chen, Zhiyang
    Wu, Weimin
    Hu, Min
    [J]. HEPATOLOGY COMMUNICATIONS, 2024, 8 (03)
12345